Last week, after my #Dabinogate article, someone sent me an email saying that I could have done more. That, in addition to talking to the manager, I should have gone ahead to report the ...

A Nigerian pharmaceutical company, ST. RACHEAL’S Pharma, has urged President Bola Tinubu to ensure the return of all ...

Three Motley Fool contributors think they've found relatively safe stocks to buy right now with major market indexes remaining near correction territory. Here's why they like Abbott Laboratories (NYSE ...

Japanese drug firm Chugai Pharmaceutical has established competitive advantages due to its alliance with majority shareholder Roche as well as its internal research and development engine. While ...

We think CR Pharma has a weaker financial position compared with the top three medical distributors. Similar to other pharmaceutical distributors, accounts receivable make up a large portion of its ...

Eli Lilly and Company, AbbVie, Merck & Co., Inc., Pfizer, D-Wave Quantum, Johnson & Johnson, and Amgen are the seven ...

Digging deeper into the BIO survey results, 94% of companies polled said they expect tariffs on the EU to drive up ...

Health care is one of the biggest industries in the U.S. economy. In 2023, it accounted for 17% of the nation’s total ...

Compounding pharmacies have emerged as a crucial player in the evolving landscape of personalized medicine, offering ...

Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine targeting a chronic blood disorder.

Two UIC professors list their questions for the man set to lead "the crown jewel” of American biomedical science.

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing ...